Abstract
Thirty-five patients (88% male) with pulmonary infection caused by Mycobacterium kansasii have been reviewed. Sixty-six per cent had pre-existing lung disease, chronic bronchitis and emphysema accounting for half of the disorders. Unilateral lesions were present in 69% of patients whose chest radiographs were reviewed and 90% had cavitating disease. The development of unilateral or bilateral disease appeared to be independent of any delay in starting treatment. Five patients died while receiving treatment, but none of these deaths was due to M kansasii infection. The remaining 30 patients were successfully treated with drug regimens, all of which included rifampicin and 86% of which included ethambutol. There was 100% sputum conversion, with no relapses after a mean follow-up period of five-and-a-half years. Rifampicin and ethambutol given for a mean period of 15 months appeared to be a non-toxic, effective combination.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson D. H., Grech P., Townshend R. H., Jephcott A. E. Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Clin Radiol. 1975 Oct;26(4):461–469. doi: 10.1016/s0009-9260(75)80097-3. [DOI] [PubMed] [Google Scholar]
- Bates J. H. A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: clinical characteristics. XX. A report of the Veterans Administration-armed forces cooperative study on the chemotherapy of tuberculosis. Am Rev Respir Dis. 1967 Dec;96(6):1151–1157. doi: 10.1164/arrd.1967.96.6.1151. [DOI] [PubMed] [Google Scholar]
- Davidson P. T., Goble M., Lester W. The antituberculosis efficacy of rifampin in 136 patients. Chest. 1972 Jun;61(6):574–578. doi: 10.1016/s0012-3692(15)39158-3. [DOI] [PubMed] [Google Scholar]
- Davidson P. T., Waggoner R. Acquired resistance to rifampicin by Mycobacterium kansasii. Tubercle. 1976 Dec;57(4):271–273. doi: 10.1016/s0041-3879(76)80005-0. [DOI] [PubMed] [Google Scholar]
- Harris G. D., Johanson W. G., Nicholson D. P. Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii. Am Rev Respir Dis. 1975 Jul;112(1):31–36. doi: 10.1164/arrd.1975.112.1.31. [DOI] [PubMed] [Google Scholar]
- Johanson W. G., Jr, Nicholson D. P. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis. 1969 Jan;99(1):73–85. doi: 10.1164/arrd.1969.99.1.73. [DOI] [PubMed] [Google Scholar]
- KAMAT S. R., ROSSITER C. E., GILSON J. C. A retrospective clinical study of pulmonary disease due to "anonymous mycobacteria" in Wales. Thorax. 1961 Sep;16:297–308. doi: 10.1136/thx.16.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. doi: 10.1164/arrd.1979.119.1.107. [DOI] [PubMed] [Google Scholar]